OCUMENSION-B (01477) spent 113,100 Hong Kong dollars to repurchase 21,000 shares on November 12th.

12/11/2024

GMT Eight

OCUMENSION-B (01477) announced that on 12 November 2024, it repurchased 21,000 shares at a total cost of HK$113,100, with a repurchase price ranging from HK$5.361 to HK$5.43 per share.

ASCLETIS-B (01672) completed the enrollment of patients in the phase III clinical trial of ASC40 (adapalene) once-daily oral tablets for the treatment of acne.

Shareholders Shanghai Tan Ying and Shanghai Tan Zheng of JUNSHI BIO (688180.SH) collectively reduced their stake in the company by 0.75%.

Contact: contact@gmteight.com

OCUMENSION-B (01477) spent 113,100 Hong Kong dollars to repurchase 21,000 shares on November 12th.

RECOMMEND

Chip Industry, Bird Startled by a Bow

Tianfeng Macro: "New Policy on Real Estate" has been in effect for a month, transaction volume rebound significantly exceeds seasonality.

National construction: Why is it important to focus on investment opportunities in the "Belt and Road" initiative currently?